Defendant Name: Orthofix International N.V.

Defendant Type: Public Company
SIC Code: 3840
CUSIP: N6748L10

Initial Case Details

Legal Case Name In the Matter of Orthofix International N.V.
First Document Date 18-Jan-2017
Initial Filing Format Administrative Action
File Number 3-17800
Allegation Type Foreign Corrupt Practices Act
AAER 3851

Violations Alleged

Exchange Act
Sec 13(b)(2)(A)
Sec 13(b)(2)(B)


First Resolution Date 18-Jan-2017
Headline Total Penalty and Disgorgement

See Related Documents

Related Documents:

34-79828 18-Jan-2017 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On January 18, 2017 the SEC instituted a settled proceeding against Orthofix International. According to the SEC: "From at least 2011 to 2013, senior personnel at Orthofix Brazil employed at least four schemes, with third-party commercial representatives and distributors, to make improper payments to doctors employed at government-owned hospitals to induce them to use Orthofix's products, thereby increasing sales. The improper payments to doctors employed at government hospitals were improperly recorded as legitimate expenses and generated illicit profits to Orthofix of approximately $2,928,000. Orthofix also failed to devise and maintain a system of internal accounting controls sufficient to provide reasonable assurances to detect and prevent such payments by Orthofix Brazil, despite the fact that Orthofix had been charged by the Commission in 2012 with violating the books and records and internal controls provisions of the FCPA in connection with bribes paid to Mexican officials by its Mexican subsidiary."
2017-18_3-17800 18-Jan-2017 Press Release--Administrative Proceeding
Medical Device Company Charged With Accounting Failures and FCPA Violations
On January 18, 2017 the SEC announced in a press release that Orthofix International has agreed to admit wrongdoing and pay a penalty to settle charges. According to the SEC: Orthofix "improperly booked revenue in certain instances and made improper payments to doctors at government-owned hospitals in Brazil in order to increase sales."